1. Início
  2. Investigação Clínica
  3. Rituximab na terapêutica da nefropatia membranosa

Rituximab na terapêutica da nefropatia membranosa

Dados básicos

Código:
Estudo Clínico Académico (Rituximab)
Protocolo:
Estudo Clínico Académico (Rituximab)
EUDRACT:
NCT:
Centro:
Dotação:
Ano de início:
2020
Ano de conclusão:
Estudos observacionais Nacional Não Financiado Outros

Objectivos do projeto

Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários

Documentos

  • Não há documentos

Participantes

Unidades de investigação

Stakeholders - Promotores

FMUP

Outputs do ensaio clínico

The gut microbiome in chronic kidney disease

Merino-Ribas A.; (...); Sampaio-Maia B.

Book Chapter. 10.1016/B978-0-323-91313-3.00012-X. 2022


Blood, Gut, and Oral Microbiome in Kidney Transplant Recipients

Sampaio, S; (...); Sampaio Maia, B.

Article. 10.4103/ijn.ijn_168_22. 2023

  • Open Access.

Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study

Cerqueira, A; (...); Pestana Vasconcelos, M.

Article. 10.3390/life11030210. 2021

  • Open Access.

Clearing the clouds: Case-report and review of the literature

Relvas, M; (...); Pestana Vasconcelos, M.

Review. 10.1111/sdi.12931. 2021


CLINICAL PREDICTORS OF COVID-19 DISEASE SEVERITY IN KIDNEY TRANSPLANT RECIPIENTS

Gonçalves, PL; (...); Pestana, M

Meeting Abstract. 2021


COVID-19 SEVERITY INFLUENCES ANTI-SARS-COV2 ANTIBODIES TITER IN KIDNEY TRANSPLANT RECIPIENTS

Gonçalves, F; (...); Pestana, M

Meeting Abstract. 2021


Endothelial Dysfunction Is Associated with Cerebrovascular Events in Pre-Dialysis CKD Patients: A Prospective Study

Cerqueira, A; (...); Pestana Vasconcelos, M.

Article. 10.3390/life11020128. 2021

  • Open Access.

Gut Microbiome and Organ Fibrosis

Costa, CFFA; (...); Alencastre, IS

Article. 10.3390/nu14020352. 2022

  • Open Access.

HERPES SIMPLEX VIRUS-2 HEPATITIS FOLLOWING KIDNEY TRANSPLANT: TAKE A SECOND LOOK

Fernandes, S; (...); Pestana, M

Meeting Abstract. 2021


Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement

Oliveira-Silva, C; (...); Tavares, I

Article. 10.1159/000525675. 2023


POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): IS THE SECRET HIDDEN IN THE SPLEEN?

Rodrigues, A; (...); Pestana, M

Meeting Abstract. 2021


Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function

Faria, B; (...); Poppelaars, F

Article. 10.1007/s40620-020-00934-7. 2021

  • Open Access.

Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways

Faria, B; (...); Poppelaars, F

Article. 10.1177/08968608231198984. 2023

  • Open Access.

The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis

Araujoa, R; (...); Sampaio-Maia, B

Article. 10.1016/j.nefro.2023.08.008. 2024

  • Open Access.

UREMIC TOXIN LEVELS ARE ASSOCIATED WITH GUT MICROBIOME CHANGES IN KIDNEY TRANSPLANT RECIPIENTS

Norton, SS; (...); Maia, MBS

Meeting Abstract. 2021


Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients

Silvano, J; (...); Pestana Vasconcelos, M.

Article. 10.1016/j.transproceed.2020.11.008. 2021

  • Open Access.

Rituximab Na Terapêutica Da Nefropatia Membranosa

Trabalho final de curso

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Rituximab Na Terapêutica Da Nefropatia Membranosa

Dissertação de Mestrado

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Sglt-2 Inhibitors And Nephroprotection: A Systematic Review And Meta-Analysis

Projeto de fim de curso

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Sglt-2 Inhibitors And Nephroprotection: A Systematic Review And Meta-Analysis

Dissertação de Mestrado

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Campos de estudo

Partilhar